Imfinzi snags another FDA nod to treat lung cancer, this time for limited-stage SCLC

The FDA has approved AstraZeneca’s Imfinzi to treat limited-stage small cell lung cancer, adding another lung cancer indication to one of the pharma’s best-selling drugs. The decision, announced by the company ...